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Introduction
Polycythemia Rubra Vera (PV) is an abnormality of
the haemopoietic stem cell characterized mainly by
erythrocytosis. Granulocytosis and thrombocytosis are also
common.1 The most common serious complications in
untreated patients are thrombotic events which include
cerebrovascular accident, myocardial infarction, deep vein
thrombosis and pulmonary embolism.2 Bleeding is also a
common complication.1,3 Over 75% of patients with
uncontrolled PV develop complications during or after
major surgery because of these complications.3 Although
vast attention has been given to peri-operative management
of anaemias in literature, there has been much less focus on
erythrocytosis which may be an equally serious condition.4
We report on a patient with uncontrolled PV who presented
with thromboembolic gangrene of the right leg and
underwent right above knee amputation under General
Anaesthesia.
Case Report
A 34 years old man with a history of Polycythemia
Vera (PV) diagnosed in 1991 was admitted to our hospital
with severe pain, swelling and discolouration of right lower
leg. His history revealed that his usual hemoglobin (Hb)
used to remain above 18g/dl. He used to get a phlebotomy
done at irregular intervals. This resulted in his having this
thromboembolic event leading to an ischemic lower limb.
His co-morbids included hypertension for 8 years and
diabetes mellitus type 1 for 3 years both of which were
controlled..
His current problem started 15 days back when he
was admitted to another hospital with the complaints of
swelling of his legs. A renal biopsy was done. Then he
developed increasing swelling and pain of the right leg
which became pulseless. For this a right femoral arterial
embolectomy was performed. By the next day his leg
developed a compartment syndrome and a fasciotomy was
done. After two days he noticed discoloration of the toes of
his right foot with increasing pain. At this point he was
brought to our hospital and was admitted under the care of
a vascular surgeon. On admission he had a temperature of
39°C and was tachypnoeic. He showed signs of congestive
cardiac failure (CCF) with sacral edema, a jugular venous
pressure of +6 cms, bilateral crepitations upto the mid zones
and a summation gallop. He also had a palpable spleen. His
right lower limb showed necrotic tissue in the fasciotomy
wounds, discolored toes and loss of sensation upto the knee.
He had a Hb of 15.9, a hematocrit (Hct) of 50.2% and a
markedly deranged coagulation. Atrial fibrillation was
detected on the electrocardiogram and the chest radiograph
showed cardiomegaly. An echocardiogram showed dilated
cardiac chambers with the left ventricular ejection fraction
of less than 25%. The rest of the investigations were within
normal limits (Table).  Intravenous antibiotics were started
and hematology and cardiology consults were sought.
The patient was started on diuretics, Angiotensin
Converting Enzyme Inhibitors, Digoxin, Broad Spectrum
Antibiotics, Ranitidine, Insulin (sliding scale), Allopurinol,
Isosorbide Mononitrates and Pethidine. The Hematologist
advised a phlebotomy to decrease the Hct and a peri-
operative transfusion of fresh frozen plasma to correct the
coagulopathy. His right leg showed rapidly growing
gangrene which needed urgent surgery with as much
optimization as possible.
His CCF improved remarkably within 24 hours. His
temperature also settled. The patient underwent right above
knee amputation under general anaesthesia . Preoperatively
he showed no signs of CCF clinically. An arterial cannula
and two large bore venous cannulae were passed.
Anaesthesia was induced with injection Fentanyl,
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Table.  Laboratory results of the patient with Polycythemia Vera.
Laboratory variables On Pre- Normal 
Admission operative range
Haematology
Haemoglobin(gm/dL) 15.8 12.1 13.7-16.3
Haematocrit (%) 50.2 38.3 41.9-48.7
Leukocytes (x109/L) 9.0 8.0 4.0-10.0
Platelets(x103/L) 363 397 150-400
Coagulation Profile
Prothrombin time(s) 110.0 19.6 10-15
Activated partial 
thromboplastin time(s) 71.6 42.1 Control 30s
INR 7 1.64 Ratio
D Dimer 1.13 0-0.5
Biochemistry
Serum Sodium (mmol/L) 140 136 136-148
Serum Potassium (mmol/L) 3.6 4.0 3.6-5.0
Glucose[fasting] (mg/dL) 179 154 65-110
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Midazolam and Propofol and a size 4 laryngeal mask airway
was inserted. Monitoring included ECG, direct arterial
pressure, pulse oximetry, capnography, temperature, urine
output and blood glucose estimates with reflo-meter. Four
units of fresh frozen plasma were transfused
intraoperatively. The patient remained hemodynamically
stable throughout the procedure. Postoperatively he was
shifted to the Special Care Unit and then to the ward the
following day. He was discharged home on the fourth
postoperative day. He remains stable at home and is being
followed up by a hematologist, a cardiologist and a
cardiothoracic surgeon for his ongoing management.
Discussion
Polycythemia Rubra Vera (PV) is a
myeloproliferative disease in which mutation of a single
cell results in increased production of erythrocytes,
leukocytes and platelets.5 Splenomegaly is also often
present.1 Hyper-viscosity of the blood leads to stasis of
blood flow and an increased incidence of vascular
thrombosis particularly in the cardiovascular system and the
central nervous system.1,6 Impaired platelet function leads
to pathological hemorrhage1,3,5 especially during or after
surgery.3,7 Acquired von Willibrand disease could be
another cause of increased bleeding tendency especially in
patients with high platelet counts.8 Wasserman and Gilbert3
evaluated two groups of patients undergoing major surgery
and having polycythemia. Of 28 patients with uncontrolled
polycythemia, 79% had complications and 36% died. Of 53
patients with controlled disease 28% had complications and
5% died. In both groups complications were related mainly
to thrombosis or haemorrhage. In the light of this study it
can be said that knowledge and pre-treatment of
polycythemia might decrease peri-operative morbidity and
mortality.
Treatment of PV includes phlebotomy and
myelosuppressive therapy e.g. Hydroxyurea, alpha
interferon, radioactive Phosphorus, etc.1 In an emergency
situation, viscosity of the blood can be reduced by
intravenous infusions of crystalloid solutions. The role of
low molecular weight dextrans has also been mentioned.6
Because of the risk of impaired platelet function and
pathological haemorrhage neuraxial anaesthetic techniques
should be considered in these patients only if the
coagulation profile and the platelet function have been
proved to be normal. The standard coagulation profile that
is the prothrombin time (PT), activated partial
thromboplastin time(aPTT) and platelet count should be
normal. Platelet function should be assessed by induced
platelet aggregation with collagen, ristocetin and adenosine
diphosphate9 and acquired von Willebrand disease should
be excluded by determination of factor VIII activity, vWF
antigen and ristocetin cofactor activity.7 If there is any doubt
of the presence of a bleeding disorder general anaesthesia
(GA) should be performed.
Our patient had a history of thrombotic myocardial
infarction in the past and had currently presented with
thrombo-embolic gangrene of the right leg. He had a
deranged PT and aPTT. This excluded the choice of regional
anaesthesia for his surgery. Although he had had two
surgeries elsewhere, his hematocrit (50.2) was still above
the acceptable safe level for anaesthesia and surgery.
Oxygen delivery is optimal at a hematocrit  value of  40-
45%.10 Cerebral oxygenation improves in man when
hematocrit is kept below 45%.11 Therefore the hematologist
advised a phlebotomy prior to surgery. His other major risk
factor was his cardiac status on admission. As his surgery
was of an urgent nature we had decided to proceed with as
much optimization as possible employing full invasive
monitoring including pulmonary artery pressure monitoring
and intubation and ventilation. Preoperatively the patient
was very well optimized and clinically showed no signs of
either septicemia or CCF. Therefore, as the surgeon had
assured a quick, bloodless surgery, we decided to initiate the
GA with a minimally invasive technique and then proceed
as required. The patient remained very stable throughout the
surgical procedure and made a quick and uneventful
recovery.
We recommend a multidisciplinary approach
towards peri-operative optimization of a patient who has
uncontrolled PV with complications. Even with controlled
PV the Haematologist should be involved early in the peri-
operative management. This might decrease the morbidity
and mortality associated with this disease although more
prospective studies are needed to prove this.12 As with
anaemias, guidelines are needed in PV regarding the safe
upper limit of Hct and the assessment of coagulation profile
and platelet function before proceeding with anaesthesia
and surgery. 
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Introduction
Unexpected pregnancy even in prolonged infertility
is not uncommon.1 This case report describes a patient with
secondary infertility for 10 years who was being submitted
to in vitro fertilization (IVF), but was diagnosed to be
pregnant during the early stages of this process thereby
emphasizing the importance of excluding pregnancy during
the reproductive years.
Case Report
A 32 year old female presented with a history of 2
miscarriages at 6 weeks of pregnancy followed by 10 years
of infertility. A bilateral wedge resection for polycystic
ovaries had been carried out 8 years ago and had resulted in
regular periods. A post-surgical laparoscopy revealed a
blocked left tube and a tortuous right tube with multiple
adhesions, which were partially freed. An unsuccessful ICSI
(Intra Cytoplasmic Sperm Injection) treatment cycle had
been carried out elsewhere. General and pelvic
examinations revealed no abnormality. 
Semen analysis of her husband showed a total count
of 915 million, the morphology showing 45% normal forms
and a motility of 70 percent (61% rapid linear progression).
Special tests revealed positive anti-nuclear
antibodies and anti-phospholipid antibody IgM levels of
15.6 m.i.u. per litre. Dispirin 75mg daily resulted in
normalization on re-testing.
The process of in vitro fertilization was started with
gonadotrophin releasing hormone agonist (GnRHa) on day
21 of the cycle. No period resulted and a plasma ßHCG on
day 30 was 153 iu/litre, diagnostic of pregnancy. The IVF
cycle was stopped. The pregnancy progressed uneventfully
and a normal male baby weighing 6 pounds 9 ounces was
delivered by caesarean section for failure to progress in
labour at 39 weeks of gestation.
Discussion
The importance of this patient lies in the exclusion of
pregnancy for all females of childbearing age no matter how
unlikely2, prior to further management or treatment.
Clinical suspicion should be present, especially taking a
careful menstrual history, and this should be confirmed,
particularly in the early stages when pelvic examination is
inconclusive and ultrasound not diagnostic.
Confirmation of pregnancy is usually carried out by
means of a urinary immunological pregnancy test. These are
designed to detect a pregnancy within 3 days of delayed
menstruation. Nevertheless, false positive results are due to
improperly stored test kits, marked proteinuria and
contamination with a vaginal discharge. False negative
results can also occur with dilute urine (S.G. <1.015) and
drug interactions.
More reliable results are obtained by measuring
serum ßHCG, although even this is not absolute due to
variation in standards.3
The occurrence of pregnancy coinciding with luteal
use of a gonadotrophin releasing hormone agonist for down
regulation of ovarian function prior to in-vitro fertilization
is noteworthy because of the prolonged infertility. It is
plausible that the early flare of increased gonadotrophins
(mainly LH)4 may have improved luteal function and hence
assisted in continuation of pregnancy.5,6
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